Search research articles
Contact Us
Filters
Showing results (181-190 of 264) with videos related to
Page
of 27
Sort By:
Blood
|
November 24, 2016
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma
Barbara Kiesewetter, Ella Willenbacher, Wolfgang Willenbacher, et al.
Endocrine Pathology
|
March 12, 2025
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung
Philipp Melhorn, Erwin Tomasich, Alissa Blessing, et al.
British Journal of Haematology
|
May 25, 2019
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis
Barbara Kiesewetter, Wolfgang Lamm, Werner Dolak, et al.
European Journal of Clinical Investigation
|
May 18, 2012
Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma
Johanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
June 6, 2022
Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients
Elisabeth L Zeilinger, Ingo W Nader, Wolfgang Wiedermann, et al.
ESMO Open
|
November 16, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
Barbara Kiesewetter, Markus Raderer, Günther G Steger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer
Werner Scheithauer, Gabriela V Kornek, Markus Raderer, et al.
Investigative Radiology
|
April 12, 2018
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
Marius E Mayerhoefer, Ulrich Jaeger, Philipp Staber, et al.
Clinical Nuclear Medicine
|
September 21, 2016
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients
Marius E Mayerhoefer, Georgios Karanikas, Kurt Kletter, et al.
Scientific Reports
|
February 24, 2019
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
Noemi Pavo, Henrike Arfsten, Anna Cho, et al.
Page
of 27
Search research articles
Search
Showing results (181-190 of 264) with videos related to
Sort By:
Page
of 27
Blood
|
November 24, 2016
A phase 2 study of rituximab plus lenalidomide for mucosa-associated lymphoid tissue lymphoma
Barbara Kiesewetter, Ella Willenbacher, Wolfgang Willenbacher, et al.
Endocrine Pathology
|
March 12, 2025
Methylation Profiles Differ According to Clinical Characteristics in Well-Differentiated Neuroendocrine Tumors of the Lung
Philipp Melhorn, Erwin Tomasich, Alissa Blessing, et al.
British Journal of Haematology
|
May 25, 2019
Transformed mucosa-associated lymphoid tissue lymphomas: A single institution retrospective study including polymerase chain reaction-based clonality analysis
Barbara Kiesewetter, Wolfgang Lamm, Werner Dolak, et al.
European Journal of Clinical Investigation
|
May 18, 2012
Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma
Johanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, et al.
International Journal of Clinical and Health Psychology : IJCHP
|
June 6, 2022
Latent structure and measurement invariance of the Hospital Anxiety and Depression Scale in cancer outpatients
Elisabeth L Zeilinger, Ingo W Nader, Wolfgang Wiedermann, et al.
ESMO Open
|
November 16, 2016
The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna
Barbara Kiesewetter, Markus Raderer, Günther G Steger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer
Werner Scheithauer, Gabriela V Kornek, Markus Raderer, et al.
Investigative Radiology
|
April 12, 2018
[68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results
Marius E Mayerhoefer, Ulrich Jaeger, Philipp Staber, et al.
Clinical Nuclear Medicine
|
September 21, 2016
Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients
Marius E Mayerhoefer, Georgios Karanikas, Kurt Kletter, et al.
Scientific Reports
|
February 24, 2019
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients
Noemi Pavo, Henrike Arfsten, Anna Cho, et al.
Page
of 27